CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine

Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncoprotein which participates in inhibiting tumor apoptosis in pancreatic cancer cells. Using immunohistochemical staining, we investigated the expression of CIP2A protein in 72 cases of human pancreatic ductal adenocarcinoma (PDAC) tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Peng, Yao, Jie, He, Jin, Zhao, Long, Wang, Xiaodong, Li, Zhennan, Qian, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924755/
https://www.ncbi.nlm.nih.gov/pubmed/26894380
http://dx.doi.org/10.18632/oncotarget.7447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924755/
https://www.ncbi.nlm.nih.gov/pubmed/26894380
http://dx.doi.org/10.18632/oncotarget.7447

Ejemplares similares